WEAVER CONSULTING GROUP – Eli Lilly and Company Transaction History
WEAVER CONSULTING GROUP portfolio value:
$216,000
portfolio value
WEAVER CONSULTING GROUP quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.75% | 5 shares | 1K | $323.35 | 669 |
| Q2 2022 | share | Decrease | -10.15% | -75 shares | 3K | $324.23 | 664 |
| Q1 2022 | share | 0.00% | 0 shares | 8K | $286.37 | 739 | |
| Q4 2021 | share | Increase | 0.00% | 739 shares | 204K | $277.25 | 739 |
| Q4 2020 | share | Decrease | -100.00% | -640 shares | -95K | $166.32 | 0 |
| Q3 2020 | share | 0.00% | 0 shares | -10K | $145.05 | 640 | |
| Q2 2020 | share | Increase | +1.43% | 9 shares | 17K | $160.1 | 640 |
| Q1 2020 | share | 0.00% | 0 shares | 17K | $134.64 | 631 | |
| Q4 2019 | share | 0.00% | 0 shares | 2K | $126.91 | 631 | |
| Q3 2019 | share | 0.00% | 0 shares | -1K | $107.36 | 631 | |
| Q2 2019 | share | 0.00% | 0 shares | -2K | $105.74 | 631 | |
| Q1 2019 | share | Increase | 0.00% | 631 shares | 72K | $123.17 | 631 |